The kit is used for the quantitative determination of the total bile acid concentration in serum. Total bile acid (TBA) is mainly used for the screening and prognosis of follow-up of hepatobiliary disease and as the marker of liver parenchymal damage and cholestasis. The increase of TBA indicates the risk of viral hepatitis, cirrhosis, alcoholic liver disease, drug-induced liver injury or cholestasis.
Range:2.5~150umol/L, r2 ≥ 0.990.
Test Principle:3alpha-hydroxycholic acid+NAD 3-Oxocholic+NADHdiaphorase NADH+INT Diaphorase NAD+formazane(red)Detect the absorbance at 505nm by colorimetry. The changes of A505 is proportional to the concentration of bile acid.
Kit Components (see Protocol for final kit quantities):Reagent 1, solution A, 36 mLx2 vial:Phosphate buffer, 100mmol/LDiaphorase, 1000U/LOxidized coenzyme I (NAD), 1mmol/LPyruvate, 50mmol/L
Calibrator, 0.25 mLx1 vial:Sodium glycocholate, check the labelPreservative, 0.5g/L
Storage and Stability:Store powder at 4°C liquid at -20°C. Store other components at 4°C. Stable for at least 6 months For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.